|
|
|
Volumn , Issue NOV., 2004, Pages 15-19
|
|
SMaRT RNA therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
APOLIPOPROTEIN A1;
BETA GALACTOSIDASE;
BLOOD CLOTTING FACTOR 8;
CD40 LIGAND;
CHORIONIC GONADOTROPIN BETA SUBUNIT;
COLLAGEN TYPE 17;
COMPLEMENTARY DNA;
MESSENGER RNA;
RECOMBINANT PROTEIN;
RNA;
TAU PROTEIN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
VIRUS ENVELOPE PROTEIN;
3' UNTRANSLATED REGION;
5' UNTRANSLATED REGION;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DRUG RESEARCH;
DYSLIPIDEMIA;
GENE EXPRESSION;
GENE TARGETING;
GENE TECHNOLOGY;
GENE THERAPY;
HEMOPHILIA A;
HUMAN;
IMMUNE DEFICIENCY;
ISCHEMIC HEART DISEASE;
NONHUMAN;
NONVIRAL GENE DELIVERY SYSTEM;
PROTEIN RNA BINDING;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RISK REDUCTION;
RNA PROCESSING;
RNA SPLICING;
RNA TRANSCRIPTION;
SEQUENCE ANALYSIS;
SPLICEOSOME;
VIRAL GENE DELIVERY SYSTEM;
|
|
EID: 10444289674
PISSN: 14727463
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
